NCT03220451

Brief Summary

All patients with a significant deficiency of skin sensitivity and reduced mobility are potentially at risk of Pressure Ulcers (PUs), in particular the persons affected by Spinal Cord Injury (SCI), also due to their frequent alteration or loss of subcutaneous skin sensitivity. Pressure sores are one of the most common and fearful complications in SCI, with a severe impact on quality of life and on care health costs. They are often the cause of lengthening the time of hospitalization, slowing down clinical and rehabilitation programs and re-hospitalization. PUs, when arisen, heal slowly and, despite the protracted conservative medical therapies, sometimes they do not come to complete healing. Sometimes plastic surgery is needed, although even after it recurrence rates remain high. Further treatments have been proposed in addition to the usual medication, however they are characterized by a certain degree of invasiveness and are often conditioned by the availability of specific and sometimes expensive equipment, as well as by the presence of highly qualified personnel. In general, there is also a lack of good quality clinical trials for assessing their effectiveness and safety and they are often not decisive, especially for severe and recalcitrant ulcers. Among alternative techniques for the healing of skin ulcers in general, the adhesive elastic bandage, also known as "kinesio taping" and already recognized for the treatment of edema, hematoma and scarring, has been proposed. However, specific protocols and published studies are not available for PUs. The Montecatone Rehabilitation Institute, that hosts the largest Spinal Unit in Italy, pays great attention to the prevention and treatment of PUs in both acute and chronic patients. The rationale for the taping positioning around PUs investigated in this study is to improve lymphatic drainage and reactivation of the superficial bloodstream by increasing interstitial spaces and reducing skin and subcutaneous compression, notoriously compromised in the areas of onset of pressure sores. The total shortage in the literature and in user manuals of taping protocols for PUs supports this preliminary, exploratory, descriptive and uncontrolled pilot study with the primary aim of verifying the safety of a taping treatment for medium/severe grade PUs, "add-on" to the usual care. The choice of the ulcer sites selected (sacral and heel) has been affected by the feasibility of tape positioning.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 11, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 18, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

September 25, 2017

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2020

Completed
Last Updated

January 20, 2021

Status Verified

January 1, 2021

Enrollment Period

2.5 years

First QC Date

July 11, 2017

Last Update Submit

January 18, 2021

Conditions

Keywords

pressure ulcerpressure soredecubitus ulcerspinal cord injuryadhesive elastic bandagetapingkinesio tapingneuro taping

Outcome Measures

Primary Outcomes (4)

  • Onset of possible adverse events due to the taping treatment

    Visual daily monitoring of possible adverse events, due to the adhesive elastic taping treatment

    Every day, during the 4-week tape application period

  • Onset of possible adverse events due to the adhesive elastic taping treatment

    Visual daily monitoring of possible adverse events, due to the adhesive elastic taping treatment

    Every day, during the 4-week follow-up after the tape application period

  • Onset of possible events hindering the healing of the pressure ulcer under investigation, due to the taping treatment

    Visual daily monitoring of possible events hindering the healing of the pressure ulcer under investigation, due to the adhesive elastic taping treatment

    Every day (during the 4-week tape application period)

  • Onset of possible events hindering the healing of the pressure ulcer under investigation, due to the taping treatment

    Visual daily monitoring of possible events hindering the healing of the pressure ulcer under investigation, due to the adhesive elastic taping treatment

    Every day (during the 4-week follow-up after the tape application period)

Secondary Outcomes (16)

  • Evolution of the characteristics of the pressure ulcer under investigation

    Baseline (initial visit); once a week during the whole study period (12 weeks)

  • Evolution of the characteristics of the pressure ulcer under investigation

    Baseline (initial visit); week 4; week 8; week 12

  • Patient's weight

    Baseline (initial visit)

  • Patient's height

    Baseline (initial visit)

  • Patient's Body Mass Index (BMI)

    Baseline (initial visit)

  • +11 more secondary outcomes

Study Arms (1)

Adhesive elastic taping

EXPERIMENTAL

After a 4-week observation of the pressure ulcer under investigation, adhesive elastic tape is applied around it for a 4-week period (the tape is changed twice a week), according to a planned application protocol. The ulcer is then observed for a subsequent follow-up period of 4 weeks.

Procedure: Adhesive elastic taping

Interventions

Adhesive elastic taping placed around a pressure ulcer, according to a planned placement technique

Adhesive elastic taping

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Spinal cord injury of any aetiology (traumatic and non-traumatic) and any neurological level, both complete and incomplete, occurred at least 3 months before;
  • Pressure ulcer occurred at least 1 month before;
  • Pressure ulcer staged III or IV, according to the National Pressure Ulcer Advisory Panel and European Pressure Ulcer Advisory Panel (NPUAP/EPUAP) classification;
  • Pressure ulcer located in sacral or heel region;
  • Pressure ulcer with cleansed bottom;
  • Stable clinical conditions;
  • Cognitive integrity and full collaboration of the subject.

You may not qualify if:

  • Ulcerative skin lesion not due to pressure;
  • Pressure ulcer with frank signs of infection or suggestive of underlying osteomyelitis;
  • Eczema and/or irritated and/or psoriatic skin around the pressure ulcer;
  • Ongoing deep venous thrombosis;
  • Known allergy to elastic adhesive tape;
  • Ongoing neoplasia;
  • Uncompensated diabetes with signs of peripheral vasculopathy;
  • Evidence of peripheral polyneuropathy;
  • Circulatory problems (e.g. severe lower limb artery disease);
  • Significant respiratory problems (e.g. with ongoing assisted ventilation);
  • Ongoing sepsis;
  • Ongoing severe clinical instability;
  • Ongoing oral anticoagulant therapy;
  • Ongoing pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Montecatone Rehabilitation Institute S.p.A.

Imola, BO, 40026, Italy

Location

MeSH Terms

Conditions

Pressure UlcerSpinal Cord Injuries

Condition Hierarchy (Ancestors)

Skin UlcerSkin DiseasesSkin and Connective Tissue DiseasesSpinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Rita Capirossi, MD Spinal U

    Montecatone Rehabilitation Institute S.p.A.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 11, 2017

First Posted

July 18, 2017

Study Start

September 25, 2017

Primary Completion

March 20, 2020

Study Completion

March 20, 2020

Last Updated

January 20, 2021

Record last verified: 2021-01

Locations